scholarly article
Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
+ JoinSee the latest ↓
The journal
Open the journal →The conversation starts in the journal — be the first to post.
The conversation starts in the journal — be the first to post.